Skip to main content
. 2021 Oct 8;11(3):106–111. doi: 10.1159/000519540

Table 1.

Comparison of gender differences in risk factor profile, clinical presentation, stroke subtype, and outcome

Variable Men Women p value
Age (mean [SD]), years 59.8 (12.7) 60.1 (13.3) 0.775
Hypertension, n (%) 322 (65.4) 165 (66) 0.881
Diabetes, n (%) 252 (51.2) 133 (53.2) 0.610
Hyperlipidemia, n (%) 192 (39) 146 (58.6) 0.000
Valvular heart disease, n (%) 20 (4.1) 32 (12.8) 0.000
Nonvalvular atrial fibrillation, n (%) 23 (4.7) 9 (3.6) 0.496
Coronary artery disease, n (%) 136 (27.6) 29 (11.6) 0.000
Tobacco smoking, n (%) 146 (29.6) 0 (0.0) 0.000
Alcohol usage, n (%) 149 (30.2) 0 (0.0) 0.000
Clinical presentation
 Weakness, n (%) 372 (75.6) 197 (78.8) 0.331
 Aphasia, n (%) 121 (24.6) 70 (28) 0.316
 Numbness, n (%) 35 (7.1) 18 (7.2) 0.966
 Blood sugar at admission, mean (±SD) 161 (75.8) 168 (73.5) 0.180
 HbA1C, mean (±SD) 7.02 (1.68) 7.27 (1.88) 0.078
 S. total cholesterol, mean (±SD) 181 (52.2) 196 (50.8) 0.000
Stroke subtype
 Large artery atherosclerosis, n (%) 105 (21.3) 37 (14.8) 0.032
 Cardioembolic, n (%) 97 (19.7) 68 (27.2) 0.020
 Valvular heart disease, n (%) 12 (12.4) 32 (47) 0.0013
 Nonvalvular atrial fibrillation, n (%) 50 (51.5) 23 (33.8) 0.024
 Others 35 (36.08) 23 (33.8) 0.92
Lacunar, n (%) 102 (20.7) 47 (18.8) 0.535
Admission NIHSS, mean (SD) 8.46 (6.62) 9.54 (6.91) 0.039
Time from onset to thrombolysis, mean (±SD), min 194 (76.2) 190 (85.0) 0.755
Rate of thrombolysis, n (%) 88 (17.8) 42 (16.8) 0.817
1. Intravenous 64 (72.7) 27 (64.3) 0.326
2. Mechanical thrombectomy 15 (17.0) 9 (21.4) 0.547
3. Bridging 9 (10.3) 6 (14.3) 0.561
Symptomatic ICH after thrombolysis 13 (14.7) 0 (0.0) 0.005
In-hospital mortality, n (%) 16 (3.3) 12 (4.8) 0.296
mRS at 3 months, 1–2, n (%) 326 (68.6) 148 (61.2) 0.046
Stroke recurrence at 3 months, n (%) 14 (2.8) 2 (0.8) 0.070
3-month mortality, n (%) 31 (6.5) 21 (8.7) 0.294